Courthouse News reports: Pharmaceutical giant Gilead Sciences triumphed over consumers Friday in a closely watched, yearslong class action that claimed the company deliberately manipulated the market in order to profit off of its highly-priced HIV treatment drugs. Closing arguments in a six-week trial wrapped Wednesday, leaving a federal jury to consider weeks of evidence regarding the pharmaceutical giant’s conduct and …
Read More »